Sarcopenia—age-related muscle loss—is emerging as a critical health concern linked to cardiovascular risk, cancer outcomes, and complications from popular weight-loss drugs. Researchers are identifying new diagnostic markers and nutritional strategies to prevent muscle deterioration in aging populations.
·A novel obesity index now predicts cardiovascular risk by accounting for muscle loss patterns
·GLP-1 receptor agonists used for weight loss are causing sarcopenia as an unintended side effect
·Chronic inflammation identified as a key driver of muscle wasting, opening new treatment possibilities
·Gait speed measurements emerging as practical screening tool for sarcopenia in diabetic older adults
·Protein alone is insufficient; six other nutrients play critical roles in maintaining muscle mass
drawn from American College of Cardiology, Harvard Health, Nature, Neurology® Journals · updated 1d ago